1. Main page
  2. Pharmaceuticals
  3. ImmunoMet Therapeutics

ImmunoMet Therapeutics

3 Decision Makers · 3 Verified Contacts

immunomet.com
📍 Houston, TXPharmaceuticals🗓 Est. 2015👥 Under 10 employees

About ImmunoMet Therapeutics

ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.

Leadership & Decision Makers

Contact details of 3 ImmunoMet Therapeutics decision makers

Edward Garmey

Consultant CMO

Sungwuk Kim

CEO

Revati Shreeniwas

Chief Medical Officer

General Emails

General company emails, e.g. customer support lines

    info@immunomet.com

    General Inquiries

    bcowen@immunomet.com

    Unclassified inbox

    dwelsch@immunomet.com

    Unclassified inbox

Verify ImmunoMet Therapeutics Emails

Similar Companies like ImmunoMet Therapeutics

Eagle Pharmaceuticals

eagleus.com
Biotechnology · Woodcliff Lake, New Jersey, United States · Est. 2007 · 101–250 employees

HQ: Woodcliff Lake, New Jersey, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals · Northbrook, Illinois, United States · Est. 2005 · 1001–5000 employees

HQ: Northbrook, Illinois, United States

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 29/07/2025

immunomet.com

+119196161923

Houston, TX

Specialization: Biopharmaceutical, Oncology, Therapeutics,
Legal Name: ImmunoMet Therapeutics, Inc.
Business Type: Private
Employees: 1-10
Rounds: Series B
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
Last Funding Type: Series B
Phone Number: +119196161923
Last Investment Activity: Jul 26, 2021
Investments Activity: Jul 26, 2021 Feb 8, 2021 Feb 21, 2018

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.